Sai Life Sciences has expanded its hydrogenation capabilities at its Unit IV manufacturing facility in Bidar, Karnataka, further strengthening its […]
Meet Sai Life Sciences at DCAT Week 2020, New York City
10 Feb 2020
Sai Life Sciences will be in
New York City for DCAT Week 2020 during March 23-26, 2020. Meet us to
know more about how we are transforming ourselves in line with the evolving
demands of our innovator customers. With investments of over US$150 million, we
are significantly expanding our R&D and manufacturing facilities, deepening
scientific & technological capabilities, strengthening automation and data
systems, and above all raising the bar for safety, quality and customer focus.
Related News
Sai Life Sciences has developed an integrated cell permeability platform to support drug discovery through automation and scalable high-throughput screening. […]
22 May 2026
Sai Life Sciences and AstraZeneca have published a study titled “ReactIR Monitoring of Turbo-Hauser Base Formation Enables a Robust Iodination […]